Breast CancerNCT04098783
Health Belief Model Based Nursing Interventions on Lymphedema Prevention
A study testing Home visit, health education in people with Breast Cancer and Breast Cancer Lymphedema, run by Ayse Cal.
Trial summary
Aim: The study was performed to examine effects of Health Belief Model based nursing interventions given at home visits on prevention of lymphedema in women having breast surgery. Methods: The study had an experimental design. Read more about this study
- Who is it for?
- Ages 28 to 77 years, women only
- Conditions the study is for
- Breast Cancer, Breast Cancer Lymphedema, Home Visit
- What is being tested?
- Home visit, health education
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 72 participants
- Where
- No sites listed yet
- Study dates
- 15 May 2016to 13 Jul 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 28 to 77 years
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Diagnosis of primary breast cancer and having stage I, II and III
- Having axillary dissection
- Not having the diagnosis of lymphedema
- Receiving radiotherapy
- Volunteering to participate in the study
- Age over 18 years
- Female
- Residing in the city
Who cannot join
- Diagnosis of bilateral breast cancer
- Open wound or infection in the upper extremities
- Musculoskeletal disorders preventing movements of the upper extremities
- Ongoing adjuvant systemic chemotherapy
About this study
Official title: Effects of Health Belief Model Based Nursing Interventions Offered at Home Visits on Lymphedema Prevention in Women With Breast Cancer: A Randomized Controlled Trial
Aim: The study was performed to examine effects of Health Belief Model based nursing interventions given at home visits on prevention of lymphedema in women having breast surgery.
Methods: The study had an experimental design. 72 women receiving radiotherapy after breast surgery, of whom 37 formed the intervention group and 35 formed the control group. The study had an experimental design. Data were collected with a personal information questionnaire, Quick-Disabilities of the Arm, Shoulder and Hand Score (Q-DASH), European Organization for Research and Treatment of Cancer Quality of Life for Breast Cancer 23 (EORTC QLQ-BR23), Strategies Used by Patients to Promote Health (SUPPH), Arm Circumference Form at three home visits at three-month intervals.
Read more
Hypotheses of the study
- Extremity function restrictions will be lower in the intervention group than in the control group.
- Self-efficacy levels will be higher in the intervention group than in the control group.
- Functions improving the quality of life will be higher in the intervention group than in the control group.
- There will be fewer symptoms reducing the quality of life in the intervention group than in the control group.
- The incidence of lymphedema will be lower in the intervention group than in the control group.
- The mean cost of the intervention group at home visits, will be lower than in the control group.
What does this paper contribute?
- Nurses can play an effective role in enabling women undergoing breast surgery to acquire behavior of lymphedema prevention. This may reduce treatment costs.
- Future research should evaluate collaborative models of care in general practice aimed at improving lymphedema prevention for women undergoing breast surgery.
- Policymakers should consider introducing funding measures for breast cancer survivors by nurses.
Read the detailed description
Aim of the study The aim of this study was to examine effects of Health Belief Model (HBM) based nursing interventions offered at home visits on lymphedema development in women undergoing breast surgery.
Study design and setting The study had a single-blind, randomized controlled experimental design. To avoid bias, the participants were not told whether they were in the experimental or the control group. The conceptual structure of the study is given. This randomized clinical trial was based on the guidelines proposed by the Consolidated Standard of Reporting Trials - CONSORT 2010. The study was conducted at homes of patients receiving treatment for breast cancer at a hospital and living in Samsun, a city in northern part of Turkey, between May 2016 and April 2017.
Randomization An intervention group and a control group were formed by using the research randomizer software. The program used random numbers to select participants and randomly assign them to the experimental or control group (100 participants were assigned to each group). Homogeneity test showed no significant difference between the measures of the groups in Table 1 (p>.05).
Blinding of data collectors and the statistician was implemented in this randomized blinded study. Another researcher who did not know the group assignments coded the data in the computer. After statistical analysis was conducted and the research report was written, the assistant researcher explained the codes for the experimental and control group. Therefore, blinding of data collectors, statistical analysis, and report writing was provided.
Study outcomes Personal Information Questionnaire;The questionnaire, developed by the researchers, is composed of 17 questions about sociodemographic characteristics, diagnosis and treatment of breast cancer, behavior of lymphedema prevention.
Quick-Disabilities of the Arm, Shoulder and Hand Score;Q-DASH is used to determine severities of disabilities in the upper extremities and benefits gained from treatment. It was adapted…by Duger et al. and its cronbach's alpha was reported to be .91. It is a five-point likert scale and includes 11 questions. The score zero indicates lack of a disability and 100 the most severe disability. Cronbach's alpha was .85 in the present study.
Strategies Used by Patients to Promote Health;SUPPH is a self-report scale created by Lev and Owen to evaluate self-efficacy of individuals in development of health promotion strategies. It was adapted by Akın and its Cronbach's alpha was reported to be .92. The scale consists of 29 items. The subscale stress reduction includes the items 1-10, making decision the items 11-13, positive attitude the items 14. Each item is scored from one to five:one corresponds to very little and five very much. The lowest and the highest scores for the scale are 29 and 145 respectively. Higher scores show higher levels of self-efficacy in self-care behavior 29. Cronbach's alpha of the scale was .91 in the present study.
European Organization for Research and Treatment of Cancer Quality of Life Scale for Breast Cancer 23;EORTC QLQ-BR23 was developed from European Organization for Research and Treatment of Cancer Quality of Life Scale 30 by EORTC to measure the quality of life in individuals with breast cancer. It was adapted…by Demirci et al. The scale is composed of 23 items, a four-point scale and has two scales named FS and SS. Cronbach's alpha was reported to be .88 for the FS .66 for the SS. The FS has the subscales body image (items 39,40,41,42), sexual functions (items 44,45), sexual satisfaction (item 46), worry about the future (item 43). The SS has the subscales side effects of systematic treatment (items 31,32,33,34,36,37,38), breast symptoms (items 50,51,52,53), arm symptoms (items 47,48,49), worry about hair loss (item 35). The lowest and the highest scores for each scale are zero and 100 respectfully. Higher scores for the FS show a higher quality of life and higher scores for the SS indicate a poorer quality of life. Cronbach's alpha was .86 for the FS, .80 for the SS.
To calculate scores for the FS and the SS, the total score for the items of each scale is divided by the total number of items and the following formulae are used:FS={1-((((total score for the items)/number of items)-1)/range)}x100 and SS={(((total score for the items)/number of items)-1)/range}x100. The highest and lowest score for the items are four and one and the difference between them, that is, three, refers to range.
Arm Circumference Measurement Form;The form was made on four different sites on both arms:at the dorsum of the hand, the wrist, and 10cm below and above of the elbow. The difference more than 2cm between circumferences of the arms was considered as significant in terms of lymphedema..
Study protocol Oral informed consent was obtained from the eligible women at the initial interviews on the phone. The women who agreed to participate in the study were assigned to the groups according to the research randomizer software. The women assigned to experimental and control groups were planned first home visit and obtained written informed consent was obtained at this visits.
At the Intervention group; the researcher made pretest (baseline measurements) before the nursing interventions at the first home visit. The researcher offered education and guide about prevention of lymphedema after the baseline measurements at the first home visit. Second and third home visits were made three and six months after the first visit. At the second and the third home visits, the measurements were repeated, and the nursing interventions were maintained in the direction of the patients' individual needs.
At the control group; the researcher administered the pretests at first home visit. The measurements were repeated in the third and sixth months after the first home visit. The researcher also given at the end of the sixth month, all of the nursing interventions, given to the intervention group, for the control group.
Intervention Education Material;Breast Cancer Related Lymphedema Education Guide, prepared in light of the literature and revised in accordance with three experts opinions, was used at home visits. The content of the guide was directed towards supporting seriousness and sensitivity of the participants about lymphedema and created by taking account of HBM.
Home Visits;At the first home visits to the intervention group, the researcher met the participants and their families, explained the aim of the study and administered the pretests. The guide was introduced, and health education was given. Arm exercises used to prevent lymphedema were demonstrated and measurement of the arm circumference was taught. Follow-up forms were introduced and from the women were asked to do exercises as daily, make measurements as weekly, and record them in the forms day to day regularly. The arm measurements made by the researcher were included into the analysis. The participants and their families were encouraged to phone and receive counseling about things which they needed. Each home visit lasted 45 minutes on average. Three and six months after the first visit, the patients were phoned and made an appointment. At the second and the third home visits, the measurements were repeated, and the nursing interventions were maintained in the direction of the patients' individual needs (repeat of education, exercises and arm circumference measurement, control of follow-up forms).
At the first home visits in the control group, the researcher was introduced herself, explained the study and administered the pretests. The measurements were repeated in the third and sixth months after the first home visit. The womens in the control group were not told about the nursing interventions, given to the intervention group, during the study period in order to avoid bias. At the end of the sixth month, education and guide about prevention of lymphedema were offered to this group.
Reminders; In the intervention group was sent a message reminding behavior Sample size calculation Before initiation of the study, to achieve 80% power, 95% confidence interval and 0.05 error range, a power analysis was made with G-power software and the sample size was found to be 14 were in each groups. However, a higher number of participants was planned to be included into the study:37 formed the intervention group, 35 formed the control group. At the end of the study, a post-hoc power analysis was made by using primary outcome variables. The post-hoc power analysis score was .98 for Q-DASH, .94 for SUPPH, .67 for the function scale (FS) and .80 for the symptom scale (SS) in EORTC QLQ-BR23.
Study budget The study was supported by The Scientific and Technological Research Council of … 1002-Short Term Funding Program (number:215S656).
Data analyses Data obtained in this study were analyzed with SPSS 21.0. Multifactorial variance analysis of repeated measures was used to compare the groups in terms of dependent variables, the significance test of difference between two means to compare pretest and posttest measures, one-way variance analysis of repeated measures to compare intragroup pretest and posttest measures and t-test for dependent groups with Bonferroni correction to perform further analysis of the difference between the mean scores of the groups. Intention-to-treat (ITT) analysis was utilized to eliminate effects of dropouts from the study, to maintain randomization. To prevent bias the database were analyzed by a statistician who was independent of the study.
Costs of treatments likely to be given for lymphedema in the intervention group and the control group due to the potential incidence of this condition and HBM based nursing interventions to be offered at home visits were made. The costs of the nursing interventions included time spent by the researcher at home visits, transportation for these visits, reminders on the phone, education material and tape measure. The cost of treatment for lymphedema included costs of medical treatment of an individual with stage I/II lymphedema in upper extremities in hospital. It was based on opinions of three experts. To calculate the costs from the perspective of Social Security Institution, prices of services and materials reported in Health Services Bulletin issued in Mar 2017 were taken. The expenses directly made by the patients were determined by the mean value of prices obtained from three national firms.
Ethical aspects Ethical approval was obtained from Dokuz Eylul University (DEU) Noninterventional Clinical Research Committee (Protocol number: 2014/08-19; approval number: 248; date: 4 April 2013 970-GOA) and … State Hospitals Directorate. Oral informed consent was obtained from the women at the initial interviews on the phone and written informed consent was obtained at the first home visits. At the end of the study, nursing interventions about prevention of lymphedema were offered to the control group.
- Conditions
- Breast Cancer, Breast Cancer Lymphedema, Home Visit
- Being tested
- Home visit, health education
- Keywords
- Breast Cancer, Lymphedema, Health Belief Model, Nursing, Home Visit
- Medical subject headings
- Breast Neoplasms, Breast Cancer Lymphedema, Lymphedema
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Home visit, health educationOther
| Study group | Role | What they receive |
|---|---|---|
| Nursing interventions (home visit and health education) group | Experimental | Nursing interventions group: Home visit, health education At the Intervention group; the researcher made pretest (baseline measurements) before the nursing interventions at the first home visit. The researcher offered education and guide about prevention of lymphedema after the baseline measurements at the first home visit. Second and third home visits were made three and six months after the first visit. At the second and the third home visits, the measurements were repeated, and the nursing interventions were maintained in the direction of the patients' individual needs. Receives: Other: Home visit, health education |
| No Nursing interventions group | No intervention | No Nursing interventions group; the researcher administered the pretests at first home visit. The measurements were repeated in the third and sixth months after the first home visit. The researcher also given at the end of the sixth month, all of the nursing interventions, given to the intervention group, for the control group. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Quick-Disabilities of the Arm, Shoulder and Hand Score
Quick-Disabilities of the Arm, Shoulder and Hand Score;Q-DASH is used to determine severities of disabilities in the upper extremities and benefits gained from treatment. It was adapted Turkish by Duger et al. and its cronbach's alpha was reported to be .91. It is a five-point likert scale and includes 11 questions. The score zero indicates lack of a disability and 100 the most severe disability.
Measured: 6 months
Strategies Used by Patients to Promote Health
Strategies Used by Patients to Promote Health;SUPPH is a self-report scale created by Lev and Owen to evaluate self-efficacy of individuals in development of health promotion strategies. It was adapted Turkey by Akın and its Cronbach's alpha was reported to be .92. The scale consists of 29 items. The subscale stress reduction includes the items 1-10, making decision the items 11-13, positive attitude the items 14. Each item is scored from one to five:one corresponds to very little and five very much. The lowest and the highest scores for the scale are 29 and 145 respectively. Higher scores show higher levels of self-efficacy in self-care behavior 29.
Measured: 6 months
European Organization for Research and Treatment of Cancer Quality of Life Scale for Breast Cancer 23
European Organization for Research and Treatment of Cancer Quality of Life Scale for Breast Cancer 23;EORTC QLQ-BR23 was adapted…by Demirci et al. The scale is composed of 23 items, a four-point scale and has two scales named FS and SS. Cronbach's alpha was reported to be .88 for the FS .66 for the SS. The FS has the subscales body image (items 39,40,41,42), sexual functions (items 44,45), sexual satisfaction (item 46), worry about the future (item 43). The SS has the subscales side effects of systematic treatment (items 31,32,33,34,36,37,38), breast symptoms (items 50,51,52,53), arm symptoms (items 47,48,49), worry about hair loss (item 35). The lowest and the highest scores for each scale are zero and 100 respectfully. Higher scores for the FS show a higher quality of life and higher scores for the SS indicate a poorer quality of life.
Measured: 6 months
Arm Circumference Measurement Form
Arm Circumference Measurement Form;The form was made on four different sites on both arms:at the dorsum of the hand, the wrist, and 10cm below and above of the elbow. The difference more than 2cm between circumferences of the arms was considered as significant in terms of lymphedema.
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Sep 2019
- Study start15 May 2016
- Primary completion15 Apr 2017
- Study completion13 Jul 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Breast CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized controlled experimental design
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 72 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ayse Cal
- Sponsor type
- University, hospital or other
- Collaborators
- The Scientific and Technological Research Council of Turkey
- Responsible party
- Sponsor-investigator, Ayse Cal, Dokuz Eylul University
- Investigators
- Ayse Cal, Asst Prof, Principal investigator, Ankara Medipol UniversityZuhal Bahar, Prof, Study director, Koç UniversityIlknur Gorken, Prof, Study chair, Dokuz Eylul University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04098783
- Sponsor's protocol ID
- 04.04.2013 970-GOA
- Status last verified
- Aug 2024
- First submitted
- 16 Sep 2019
- Last updated
- 7 Aug 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Aug 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Health Belief Model Based Nursing Interventions Offered at Home Visits on Lymphedema Prevention in Women With Breast Cancer: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT04098783
- Acronym / sponsor ID
- 04.04.2013 970-GOA
- Conditions
- Breast Cancer, Breast Cancer Lymphedema, Home Visit
- Keywords
- Breast Cancer, Lymphedema, Health Belief Model, Nursing, Home Visit
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 72 participants (actual)
- Lead sponsor
- Ayse CalUniversity, hospital or other
- Collaborators
- The Scientific and Technological Research Council of Turkey
- Study start
- 15 May 2016 (actual)
- Primary completion
- 15 Apr 2017 (actual)
- Study completion
- 13 Jul 2017 (actual)
- First posted
- 23 Sep 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Aim: The study was performed to examine effects of Health Belief Model based nursing interventions given at home visits on prevention of lymphedema in women having breast surgery.
Methods: The study had an experimental design. 72 women receiving radiotherapy after breast surgery, of whom 37 formed the intervention group and 35 formed the control group. The study had an experimental design. Data were collected with a personal information questionnaire, Quick-Disabilities of the Arm, Shoulder and Hand Score (Q-DASH), European Organization for Research and Treatment of Cancer Quality of Life for Breast Cancer 23 (EORTC QLQ-BR23), Strategies Used by Patients to Promote Health (SUPPH), Arm Circumference Form at three home visits at three-month intervals.
Hypotheses of the study
- Extremity function restrictions will be lower in the intervention group than in the control group.
- Self-efficacy levels will be higher in the intervention group than in the control group.
- Functions improving the quality of life will be higher in the intervention group than in the control group.
- There will be fewer symptoms reducing the quality of life in the intervention group than in the control group.
- The incidence of lymphedema will be lower in the intervention group than in the control group.
- The mean cost of the intervention group at home visits, will be lower than in the control group.
What does this paper contribute?
- Nurses can play an effective role in enabling women undergoing breast surgery to acquire behavior of lymphedema prevention. This may reduce treatment costs.
- Future research should evaluate collaborative models of care in general practice aimed at improving lymphedema prevention for women undergoing breast surgery.
- Policymakers should consider introducing funding measures for breast cancer survivors by nurses.
Detailed description
Aim of the study The aim of this study was to examine effects of Health Belief Model (HBM) based nursing interventions offered at home visits on lymphedema development in women undergoing breast surgery.
Study design and setting The study had a single-blind, randomized controlled experimental design. To avoid bias, the participants were not told whether they were in the experimental or the control group. The conceptual structure of the study is given. This randomized clinical trial was based on the guidelines proposed by the Consolidated Standard of Reporting Trials - CONSORT 2010. The study was conducted at homes of patients receiving treatment for breast cancer at a hospital and living in Samsun, a city in northern part of Turkey, between May 2016 and April 2017.
Randomization An intervention group and a control group were formed by using the research randomizer software. The program used random numbers to select participants and randomly assign them to the experimental or control group (100 participants were assigned to each group). Homogeneity test showed no significant difference between the measures of the groups in Table 1 (p>.05).
Blinding of data collectors and the statistician was implemented in this randomized blinded study. Another researcher who did not know the group assignments coded the data in the computer. After statistical analysis was conducted and the research report was written, the assistant researcher explained the codes for the experimental and control group. Therefore, blinding of data collectors, statistical analysis, and report writing was provided.
Study outcomes Personal Information Questionnaire;The questionnaire, developed by the researchers, is composed of 17 questions about sociodemographic characteristics, diagnosis and treatment of breast cancer, behavior of lymphedema prevention.
Quick-Disabilities of the Arm, Shoulder and Hand Score;Q-DASH is used to determine severities of disabilities in the upper extremities and benefits gained from treatment. It was adapted…by Duger et al. and its cronbach's alpha was reported to be .91. It is a five-point likert scale and includes 11 questions. The score zero indicates lack of a disability and 100 the most severe disability. Cronbach's alpha was .85 in the present study.
Strategies Used by Patients to Promote Health;SUPPH is a self-report scale created by Lev and Owen to evaluate self-efficacy of individuals in development of health promotion strategies. It was adapted by Akın and its Cronbach's alpha was reported to be .92. The scale consists of 29 items. The subscale stress reduction includes the items 1-10, making decision the items 11-13, positive attitude the items 14. Each item is scored from one to five:one corresponds to very little and five very much. The lowest and the highest scores for the scale are 29 and 145 respectively. Higher scores show higher levels of self-efficacy in self-care behavior 29. Cronbach's alpha of the scale was .91 in the present study.
European Organization for Research and Treatment of Cancer Quality of Life Scale for Breast Cancer 23;EORTC QLQ-BR23 was developed from European Organization for Research and Treatment of Cancer Quality of Life Scale 30 by EORTC to measure the quality of life in individuals with breast cancer. It was adapted…by Demirci et al. The scale is composed of 23 items, a four-point scale and has two scales named FS and SS. Cronbach's alpha was reported to be .88 for the FS .66 for the SS. The FS has the subscales body image (items 39,40,41,42), sexual functions (items 44,45), sexual satisfaction (item 46), worry about the future (item 43). The SS has the subscales side effects of systematic treatment (items 31,32,33,34,36,37,38), breast symptoms (items 50,51,52,53), arm symptoms (items 47,48,49), worry about hair loss (item 35). The lowest and the highest scores for each scale are zero and 100 respectfully. Higher scores for the FS show a higher quality of life and higher scores for the SS indicate a poorer quality of life. Cronbach's alpha was .86 for the FS, .80 for the SS.
To calculate scores for the FS and the SS, the total score for the items of each scale is divided by the total number of items and the following formulae are used:FS={1-((((total score for the items)/number of items)-1)/range)}x100 and SS={(((total score for the items)/number of items)-1)/range}x100. The highest and lowest score for the items are four and one and the difference between them, that is, three, refers to range.
Arm Circumference Measurement Form;The form was made on four different sites on both arms:at the dorsum of the hand, the wrist, and 10cm below and above of the elbow. The difference more than 2cm between circumferences of the arms was considered as significant in terms of lymphedema..
Study protocol Oral informed consent was obtained from the eligible women at the initial interviews on the phone. The women who agreed to participate in the study were assigned to the groups according to the research randomizer software. The women assigned to experimental and control groups were planned first home visit and obtained written informed consent was obtained at this visits.
At the Intervention group; the researcher made pretest (baseline measurements) before the nursing interventions at the first home visit. The researcher offered education and guide about prevention of lymphedema after the baseline measurements at the first home visit. Second and third home visits were made three and six months after the first visit. At the second and the third home visits, the measurements were repeated, and the nursing interventions were maintained in the direction of the patients' individual needs.
At the control group; the researcher administered the pretests at first home visit. The measurements were repeated in the third and sixth months after the first home visit. The researcher also given at the end of the sixth month, all of the nursing interventions, given to the intervention group, for the control group.
Intervention Education Material;Breast Cancer Related Lymphedema Education Guide, prepared in light of the literature and revised in accordance with three experts opinions, was used at home visits. The content of the guide was directed towards supporting seriousness and sensitivity of the participants about lymphedema and created by taking account of HBM.
Home Visits;At the first home visits to the intervention group, the researcher met the participants and their families, explained the aim of the study and administered the pretests. The guide was introduced, and health education was given. Arm exercises used to prevent lymphedema were demonstrated and measurement of the arm circumference was taught. Follow-up forms were introduced and from the women were asked to do exercises as daily, make measurements as weekly, and record them in the forms day to day regularly. The arm measurements made by the researcher were included into the analysis. The participants and their families were encouraged to phone and receive counseling about things which they needed. Each home visit lasted 45 minutes on average. Three and six months after the first visit, the patients were phoned and made an appointment. At the second and the third home visits, the measurements were repeated, and the nursing interventions were maintained in the direction of the patients' individual needs (repeat of education, exercises and arm circumference measurement, control of follow-up forms).
At the first home visits in the control group, the researcher was introduced herself, explained the study and administered the pretests. The measurements were repeated in the third and sixth months after the first home visit. The womens in the control group were not told about the nursing interventions, given to the intervention group, during the study period in order to avoid bias. At the end of the sixth month, education and guide about prevention of lymphedema were offered to this group.
Reminders; In the intervention group was sent a message reminding behavior Sample size calculation Before initiation of the study, to achieve 80% power, 95% confidence interval and 0.05 error range, a power analysis was made with G-power software and the sample size was found to be 14 were in each groups. However, a higher number of participants was planned to be included into the study:37 formed the intervention group, 35 formed the control group. At the end of the study, a post-hoc power analysis was made by using primary outcome variables. The post-hoc power analysis score was .98 for Q-DASH, .94 for SUPPH, .67 for the function scale (FS) and .80 for the symptom scale (SS) in EORTC QLQ-BR23.
Study budget The study was supported by The Scientific and Technological Research Council of … 1002-Short Term Funding Program (number:215S656).
Data analyses Data obtained in this study were analyzed with SPSS 21.0. Multifactorial variance analysis of repeated measures was used to compare the groups in terms of dependent variables, the significance test of difference between two means to compare pretest and posttest measures, one-way variance analysis of repeated measures to compare intragroup pretest and posttest measures and t-test for dependent groups with Bonferroni correction to perform further analysis of the difference between the mean scores of the groups. Intention-to-treat (ITT) analysis was utilized to eliminate effects of dropouts from the study, to maintain randomization. To prevent bias the database were analyzed by a statistician who was independent of the study.
Costs of treatments likely to be given for lymphedema in the intervention group and the control group due to the potential incidence of this condition and HBM based nursing interventions to be offered at home visits were made. The costs of the nursing interventions included time spent by the researcher at home visits, transportation for these visits, reminders on the phone, education material and tape measure. The cost of treatment for lymphedema included costs of medical treatment of an individual with stage I/II lymphedema in upper extremities in hospital. It was based on opinions of three experts. To calculate the costs from the perspective of Social Security Institution, prices of services and materials reported in Health Services Bulletin issued in Mar 2017 were taken. The expenses directly made by the patients were determined by the mean value of prices obtained from three national firms.
Ethical aspects Ethical approval was obtained from Dokuz Eylul University (DEU) Noninterventional Clinical Research Committee (Protocol number: 2014/08-19; approval number: 248; date: 4 April 2013 970-GOA) and … State Hospitals Directorate. Oral informed consent was obtained from the women at the initial interviews on the phone and written informed consent was obtained at the first home visits. At the end of the study, nursing interventions about prevention of lymphedema were offered to the control group.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
- Model description
- Randomized controlled experimental design
| Arm | Type | Receives |
|---|---|---|
| Nursing interventions (home visit and health education) group | Experimental | Other: Home visit, health educationNursing interventions group: Home visit, health education At the Intervention group; the researcher made pretest (baseline measurements) before the nursing interventions at the first home visit. The researcher offered education and guide about prevention of lymphedema after the baseline measurements at the first home visit. Second and third home visits were made three and six months after the first visit. At the second and the third home visits, the measurements were repeated, and the nursing interventions were maintained in the direction of the patients' individual needs. |
| No Nursing interventions group | No intervention | –No Nursing interventions group; the researcher administered the pretests at first home visit. The measurements were repeated in the third and sixth months after the first home visit. The researcher also given at the end of the sixth month, all of the nursing interventions, given to the intervention group, for the control group. |
Who may qualify
- Ages
- 28 to 77 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (8 listed)
- Diagnosis of primary breast cancer and having stage I, II and III
- Having axillary dissection
- Not having the diagnosis of lymphedema
- Receiving radiotherapy
- Volunteering to participate in the study
Key exclusion criteria (4 listed)
- Diagnosis of bilateral breast cancer
- Open wound or infection in the upper extremities
- Musculoskeletal disorders preventing movements of the upper extremities
- Ongoing adjuvant systemic chemotherapy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Home visit, health education | Other | Nursing interventions (home visit and health education) group |
Primary outcome
Quick-Disabilities of the Arm, Shoulder and Hand Score
Time frame: 6 months
Quick-Disabilities of the Arm, Shoulder and Hand Score;Q-DASH is used to determine severities of disabilities in the upper extremities and benefits gained from treatment. It was adapted Turkish by Duger et al. and its cronbach's alpha was reported to be .91. It is a five-point likert scale and includes 11 questions. The score zero indicates lack of a disability and 100 the most severe disability.
Strategies Used by Patients to Promote Health
Time frame: 6 months
Strategies Used by Patients to Promote Health;SUPPH is a self-report scale created by Lev and Owen to evaluate self-efficacy of individuals in development of health promotion strategies. It was adapted Turkey by Akın and its Cronbach's alpha was reported to be .92. The scale consists of 29 items. The subscale stress reduction includes the items 1-10, making decision the items 11-13, positive attitude the items 14. Each item is scored from one to five:one corresponds to very little and five very much. The lowest and the highest scores for the scale are 29 and 145 respectively. Higher scores show higher levels of self-efficacy in self-care behavior 29.
European Organization for Research and Treatment of Cancer Quality of Life Scale for Breast Cancer 23
Time frame: 6 months
European Organization for Research and Treatment of Cancer Quality of Life Scale for Breast Cancer 23;EORTC QLQ-BR23 was adapted…by Demirci et al. The scale is composed of 23 items, a four-point scale and has two scales named FS and SS. Cronbach's alpha was reported to be .88 for the FS .66 for the SS. The FS has the subscales body image (items 39,40,41,42), sexual functions (items 44,45), sexual satisfaction (item 46), worry about the future (item 43). The SS has the subscales side effects of systematic treatment (items 31,32,33,34,36,37,38), breast symptoms (items 50,51,52,53), arm symptoms (items 47,48,49), worry about hair loss (item 35). The lowest and the highest scores for each scale are zero and 100 respectfully. Higher scores for the FS show a higher quality of life and higher scores for the SS indicate a poorer quality of life.
Arm Circumference Measurement Form
Time frame: 6 months
Arm Circumference Measurement Form;The form was made on four different sites on both arms:at the dorsum of the hand, the wrist, and 10cm below and above of the elbow. The difference more than 2cm between circumferences of the arms was considered as significant in terms of lymphedema.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Aug 2024.
- Individual participant dataSharing planned: No
Related trials for Breast Cancer
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 2
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Invasive Mammary Carcinoma, Metastatic Breast Cancer
Not yet recruitingObservational study
Comparison of Reliability, Time Cost, and Participant Comfort of Lymphedema Assessments in Upper Extremity
Lymphedema, Upper Extremity Lymphedema
RecruitingPhase 3
A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
TNBC - Triple-Negative Breast Cancer
RecruitingPhase 3
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ayse Cal, Asst Prof principal investigator
Ankara Medipol University
Zuhal Bahar, Prof study director
Koç University
Ilknur Gorken, Prof study chair
Dokuz Eylul University
Questions about this trial
What is this clinical trial studying?
A study testing Home visit, health education in people with Breast Cancer and Breast Cancer Lymphedema, run by Ayse Cal.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Quick-Disabilities of the Arm, Shoulder and Hand Score (time frame: 6 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2024.